Teleflex (TFX)
(Delayed Data from NYSE)
$211.17 USD
+0.06 (0.03%)
Updated Apr 24, 2024 04:00 PM ET
After-Market: $211.16 -0.01 (0.00%) 7:58 PM ET
4-Sell of 5 4
B Value D Growth B Momentum C VGM
Brokerage Reports
0 items in cart
Teleflex Incorporated [TFX]
Reports for Purchase
Showing records 161 - 180 ( 460 total )
Company: Teleflex Incorporated
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department
Company: Teleflex Incorporated
Industry: Medical - Instruments
Comprehensive Technical and Fundamental Analysis for TFX.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Teleflex Incorporated
Industry: Medical - Instruments
Company: Teleflex Incorporated
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department
Company: Teleflex Incorporated
Industry: Medical - Instruments
Strategically Important Step to LT International Expansion
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Teleflex Incorporated
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department
Company: Teleflex Incorporated
Industry: Medical - Instruments
Company: Teleflex Incorporated
Industry: Medical - Instruments
Company: Teleflex Incorporated
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department
Company: Teleflex Incorporated
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department
Company: Teleflex Incorporated
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department
Company: Teleflex Incorporated
Industry: Medical - Instruments
Company: Teleflex Incorporated
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department
Company: Teleflex Incorporated
Industry: Medical - Instruments
Final Rule Appears in Line with Our Base Case Assumption
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Teleflex Incorporated
Industry: Medical - Instruments
Company: Teleflex Incorporated
Industry: Medical - Instruments
UroLift Miss and Guidedown Likely the Primary Focus; Margins Driving Better EPS Though
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Teleflex Incorporated
Industry: Medical - Instruments
Hard to Explain UroLift Miss and Guidance Revision Just from COVID
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Teleflex Incorporated
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department